In this video, I will cover why Amazon, Intel (NASDAQ:INTC), and Reddit sold off after earnings, whether the AI trade is really over, and what I'm doing with my Amazon and Reddit shares. Watch the short video to learn more, consider subscribing, and click the special offer link b
The average one-year price target for TPG Mortgage Investment Trust, Inc. - Preferred Stock (NYSE:MITT.PRA) has been revised to $35.47 per share. This represents an increase of 24.91% from the prior estimate of $28.39 dated November 1, 2026. These figures represent aggregate anal
The average one-year price target for TPG Mortgage Investment Trust, Inc. - Preferred Stock (NYSE:MITT.PRA) has been revised to $35.47 per share. This represents an increase of 24.91% from the prior estimate of $28.39 dated November 1, 2026. These figures represent aggregate anal
(RTTNews) - Packaging company Sonoco Products Co. (SON) announced the retirement of Chief Executive Officer Howard Coker on Monday and named Ernest Haynes as its next CEO, effective January 1, 2027.
(RTTNews) - Packaging company Sonoco Products Co. (SON) announced the retirement of Chief Executive Officer Howard Coker on Monday and named Ernest Haynes as its next CEO, effective January 1, 2027.
Abeona Therapeutics Inc. reported its third-quarter 2026 financial results and provided an update on the commercial progress of ZEVASKYN. For the quarter ended September 30, 2026, net ZEVASKYN revenue was $13.5 million, representing an 18% increase compared with $11.4 million for
Vivid Seats Inc. announced on November 9, 2026, that it has reached an agreement in principle with an ad hoc group of term lenders on the material terms of a comprehensive recapitalization and deleveraging transaction. Under the terms currently contemplated, the proposed transact
ImmunityBio, Inc. announced positive results from the final analysis of the primary endpoint in Cohort A of QUILT-2.005, a randomized, controlled, registrational trial evaluating intravesical ANKTIVA in combination with Bacillus Calmette-Guérin (BCG) versus BCG alone in pa
Abeona Therapeutics Inc. reported its third-quarter 2026 financial results and provided an update on the commercial progress of ZEVASKYN. For the quarter ended September 30, 2026, net ZEVASKYN revenue was $13.5 million, representing an 18% increase compared with $11.4 million for
Vivid Seats Inc. announced on November 9, 2026, that it has reached an agreement in principle with an ad hoc group of term lenders on the material terms of a comprehensive recapitalization and deleveraging transaction. Under the terms currently contemplated, the proposed transact
(RTTNews) - CorMedix Therapeutics (CRMD) and Heron Therapeutics (HRTX) entered into a definitive agreement under which CorMedix will acquire substantially all of Heron's assets, expanding its portfolio of products used in hospitals, ambulatory surgical centers and infusion center
(RTTNews) - Tonix Pharmaceuticals Holding Corp. (TNXP) reported a wider third-quarter loss Monday as research and commercial expenses increased. Net product revenue rose to $17.23 million, led by Tonmya sales.
Intel's 56.5% stock plunge, weak Q4 outlook and China headwinds raise concerns, even as foundry growth and AI investments bolster its turnaround prospects.
Intel's 56.5% stock plunge, weak Q4 outlook and China headwinds raise concerns, even as foundry growth and AI investments bolster its turnaround prospects.
When Jonathan Kanter stepped down as head of the Justice Department's Antitrust Division in 2024, he set out to keep fighting to dismantle illegal monopolies. But this time, he's continuing the fight in the private sector, and with a perhaps unexpected tool: AI. Alongside former acting Antitrust Division chief Doha Mekki, Kanter recently launched a […]